Abstract:Abstract Background Genome-wide association studies (GWASs) have identified 320 loci associated with inflammatory bowel disease (IBD). About 15% of these loci include genes that lie in pathways targeted by drugs currently approved to treat IBD. Thus, identifying new loci can not only provide further insights into causal biology but also reveal novel therapeutic targets. Methods We performed a multi-ancestry GWAS meta-analysis of 67 cohorts, from European, East Asian and South Asian populations. The final dataset included 125,992 IBD patients (59,734 with CD; 57,565 with UC) and more than 1.2 million population controls (Fig 1). Genotype imputation was undertaken using the TOPMed diverse population panel and association tests were performed using REGENIE. The results were meta-analysed using a fixed effects meta-analysis via Metal. To prioritise effector genes and generate therapeutic hypotheses, we integrated our results with bulk and single cell transcriptome data from relevant tissues and cell types. Through colocalization analyses we identified those signals driving the expression of nearby genes (cis-eQTL), suggesting that aberrant expression of these genes underpins the association. Results We identified 290 new independent disease susceptibility association signals. Out of these, 125 new signals are located >1Mb from any previously reported loci. Six new loci contain genes implicated in monogenic syndromes that include colitis GUCY2C, G6PC3, NFKBIA, PIK3CD, PIK3R1, ZBTB24. Up to 40% of all disease susceptibility association signals colocalize with a cis-eQTL. For instance, a new variant associated with increased risk of UC (P=8x10-14) decreases the expression of the transmembrane mitochondrial protein TSPO in T cells, B cells, macrophages, and transverse colon. Pro-inflammatory macrophages show consistent TSPO downregulation. Loss of TSPO in mice causes exacerbated DSS-induced colitis. Ongoing clinical trials are evaluating whether targeting this gene could ameliorate the immune response in multiple sclerosis patients. We also identified a new CD susceptibility variant (P=3x10-16) associated with increased expression of WNK1 in monocytes and macrophages. Whereas loss of WNK1 in mice show increased expression of IL-1B in response to NLRP3 inflammasome activation; it also stimulates autophagy through the upregulation of the PI3KC3 complex. Impaired autophagy has shown to be key in promoting CD susceptibility. Conclusion Integrating molecular data from multiple cell types and conditions not only expands our ability to determine novel candidate causal genes, it also provides additional evidence of the utility of genetics as an instrument to guide the development of new therapeutic drugs or the repurposing of existing molecules.

An isoform quantitative trait locus in SBNO2 links genetic susceptibility to Crohn's disease with defective antimicrobial activity

Association of Polymorphisms in the IL‐10 Promoter Region with Crohn's Disease

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

A Novel Function of the Crohn’s Disease—associated Nod2 Mutant 1007 Fs in the Regulation of Human IL10 Gene Transcription

Vitamin D Metabolism-related Gene Polymorphisms in Crohn's Disease

Su1766 Phenotype of Peripheral T Lymphocyte Did Not Correlate with Genotype at Rs7746082, a Confirmed Focal SNP on 6q21 for Crohn's Disease Susceptibility

A Novel Susceptibility Locus in MST1 and Gene‐gene Interaction Network for Crohn's Disease in the Chinese Population

OP08 Multi-ancestry genome-wide association study of inflammatory bowel disease identifies 125 novel loci and directly implicates new genes in disease susceptibility

Inflammation status modulates the effect of host genetic variation on intestinal gene expression in inflammatory bowel disease

Identification of Two Additional Susceptibility Loci for Inflammatory Bowel Disease in a Chinese Population.

Phenotype-Stratified Genetic Linkage Study Demonstrates That Ibd2 is an Extensive Ulcerative Colitis Locus

Relation Between NOD2 Genotype and Changes in Innate Signaling in Crohn’s Disease on Mrna and Mirna Levels

Deleterious Genetic Variation Across the NOD Signaling Pathway Is Associated With Reduced NFKB Signaling Transcription and Upregulation of Alternative Inflammatory Transcripts in Pediatric Inflammatory Bowel Disease

The relationship between extreme inter-individual variation in macrophage gene expression and genetic susceptibility to inflammatory bowel disease

Nod2 Status And Human Ileal Gene Expression

Trans-ancestry, Bayesian meta-analysis discovers 20 novel risk loci for inflammatory bowel disease in an African American, East Asian and European cohort

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

OCTN1 Variant L503F is Associated with Familial and Sporadic Inflammatory Bowel Disease.

Genetic Variation at the Chromosome 16 Chemokine Gene Cluster: Development of a Strategy for Association Studies in Complex Disease

Identification of A Common Variant with Potential Pleiotropic Effect on Risk of Inflammatory Bowel Disease and Colorectal Cancer

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease